Why is Q4 2025 EPS guidance growing much more slowly than sales guidance?

Management guided Q4 sales up about 10% but adjusted EPS of $1.90 to $1.95, up only 2% to 4%. The filing does not explain the gap in detail. Likely drivers include acquisition-related dilution from recent deals such as FARO, integration costs, higher amortization or other expense, and a higher effective tax rate. Investors should look for management commentary on the Q4 margin outlook on the earnings call.

How much of the growth came from acquisitions versus organic performance?

The release separates acquisition effects in several places. Management cited about 90 basis points of consolidated margin expansion excluding recent acquisitions, and 50 basis points of EIG margin expansion excluding acquisitions. Acquisitions also dilute reported margins: EIG's GAAP margin of 28.3% reflects a 1.5-point dilutive impact from acquisitions. The release does not provide a full organic sales growth figure, so investors should check the 10-Q or the call for the organic breakdown.

What are the main one-time or non-GAAP adjustments affecting the quarter?

Acquisition-related costs of $19.7 million pre-tax (about $0.07 per diluted share after tax) were excluded from adjusted results, mainly tied to the FARO Technologies acquisition. Integration costs sit in cost of sales and transaction costs sit in other expense. Adjusted EPS also adds back non-cash, after-tax acquisition intangible amortization of $0.22 per share. Investors should weigh GAAP EPS of $1.60 alongside adjusted EPS of $1.89, since the gap is meaningful.

How has AMETEK's leverage and balance sheet changed?

Total debt, including the current portion, rose to about $2.46 billion at September 30, 2025, from about $2.08 billion at year-end 2024, mainly through short-term borrowings that increased to $1.04 billion. Long-term debt was essentially flat at $1.43 billion. Cash rose to $439 million. Goodwill increased by about $630 million to $7.19 billion, consistent with acquisitions. Interest expense declined to $58.4 million for nine months from $91.0 million, indicating lower borrowing costs or reduced debt levels during the period.

AME 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed October 30, 2025. Cited figures are marked; the original filing is the authoritative source.

AMETEK (NYSE: AME) reported record third-quarter 2025 results, with sales of $1.89 billion^a, up 11% year over year, and GAAP diluted EPS of $1.60.

Adjusted diluted EPS was a record $1.89^b, up 14%. GAAP operating income reached a record $488.4 million, or 25.8% of sales. Growth was broad-based: Electronic Instruments Group (EIG) sales rose 10% to $1.25 billion, and Electromechanical Group (EMG) sales rose 13% to $646.3 million, with EMG operating margin expanding 250 basis points to 25.4%, led by Paragon Medical.

Management attributed about 90 basis points of margin expansion, excluding recent acquisitions, to the quarter. The FARO Technologies acquisition is contributing, though it carried $19.7 million^c of pre-tax acquisition-related costs in the quarter. The key forward-looking change is a raised 2025 outlook.

Management now expects full-year adjusted EPS of $7.32 to $7.37^d, up from the prior $7.06 to $7.20 range and representing 7% to 8% growth. Full-year sales growth is still guided to the mid-single digits. For Q4 2025, management expects sales up about 10% and adjusted EPS of $1.90 to $1.95, up 2% to 4% year over year.

The implied Q4 EPS growth is much slower than the sales growth, which investors should weigh against the margin and acquisition-cost assumptions. Balance sheet activity points to continued acquisition-driven growth. Goodwill rose to $7.19 billion from $6.56 billion at year-end 2024, and total debt including current portion rose to about $2.46 billion from about $2.08 billion.

Cash was $439 million. Stockholders' equity grew to $10.5 billion.

Nine-month operating income was $1.40 billion, and interest expense fell sharply to $58.4 million from $91.0 million, supporting earnings. Note that this 8-K furnishes the earnings release under Item 2.02, so the information is not deemed filed under Section 18 of the Exchange Act.

02—Key points

Key Highlights

Record Q3 2025 sales of $1.89 billion, up 11% year over year, with GAAP diluted EPS of $1.60 and adjusted diluted EPS of a record $1.89, up 14%.
Record GAAP operating income of $488.4 million (25.8% margin); adjusted operating income of $496.1 million, up 11%.
EIG sales of $1.25 billion, up 10%, with adjusted operating income of $360.2 million, up 6%; management cited 50 basis points of margin expansion excluding acquisitions.
EMG sales of $646.3 million, up 13%, and operating income up 25% to a record $163.9 million; operating margin expanded 250 basis points to 25.4%, led by Paragon Medical.
Raised 2025 adjusted EPS guidance to $7.32 to $7.37 from $7.06 to $7.20, while maintaining mid-single-digit full-year sales growth.
Q4 2025 guidance calls for sales up about 10% and adjusted EPS of $1.90 to $1.95 (up 2% to 4%), implying a sharp deceleration in EPS growth versus sales growth.
Goodwill rose to $7.19 billion from $6.56 billion and total debt rose to about $2.46 billion, reflecting acquisition activity including FARO Technologies, while interest expense fell 36% year to date.

03—Questions

Frequently Asked Questions

Why is Q4 2025 EPS guidance growing much more slowly than sales guidance?
Management guided Q4 sales up about 10% but adjusted EPS of $1.90 to $1.95, up only 2% to 4%. The filing does not explain the gap in detail. Likely drivers include acquisition-related dilution from recent deals such as FARO, integration costs, higher amortization or other expense, and a higher effective tax rate. Investors should look for management commentary on the Q4 margin outlook on the earnings call.
How much of the growth came from acquisitions versus organic performance?
The release separates acquisition effects in several places. Management cited about 90 basis points of consolidated margin expansion excluding recent acquisitions, and 50 basis points of EIG margin expansion excluding acquisitions. Acquisitions also dilute reported margins: EIG's GAAP margin of 28.3% reflects a 1.5-point dilutive impact from acquisitions. The release does not provide a full organic sales growth figure, so investors should check the 10-Q or the call for the organic breakdown.
What are the main one-time or non-GAAP adjustments affecting the quarter?
Acquisition-related costs of $19.7 million pre-tax (about $0.07 per diluted share after tax) were excluded from adjusted results, mainly tied to the FARO Technologies acquisition. Integration costs sit in cost of sales and transaction costs sit in other expense. Adjusted EPS also adds back non-cash, after-tax acquisition intangible amortization of $0.22 per share. Investors should weigh GAAP EPS of $1.60 alongside adjusted EPS of $1.89, since the gap is meaningful.
How has AMETEK's leverage and balance sheet changed?
Total debt, including the current portion, rose to about $2.46 billion at September 30, 2025, from about $2.08 billion at year-end 2024, mainly through short-term borrowings that increased to $1.04 billion. Long-term debt was essentially flat at $1.43 billion. Cash rose to $439 million. Goodwill increased by about $630 million to $7.19 billion, consistent with acquisitions. Interest expense declined to $58.4 million for nine months from $91.0 million, indicating lower borrowing costs or reduced debt levels during the period.

04—Continue

← View all 8-K filings